Patents by Inventor Elizabeth J. Brown

Elizabeth J. Brown has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR DIAGNOSING AND ASSESSING RISK OF DEVELOPING GLOMERULOSCLEROSIS
    Publication number: 20210198740
    Abstract: This document features method related to variants in the Inverted Formin 2 (INF2) gene that are associated with susceptibility to focal segmental glomerulosclerosis (FSGS). For example, methods of using such variants for risk assessment and for diagnosing and optimizing treatment of FSGS are provided.
    Type: Application
    Filed: December 7, 2020
    Publication date: July 1, 2021
    Inventors: Martin Pollak, Elizabeth J. Brown, Johannes Schlondorff
  • Methods for diagnosing and assessing risk of developing glomerulosclerosis
    Patent number: 10858705
    Abstract: This document features method related to variants in the Inverted Formin 2 (INF2) gene that are associated with susceptibility to focal segmental glomerulosclerosis (FSGS). For example, methods of using such variants for risk assessment and for diagnosing and optimizing treatment of FSGS are provided.
    Type: Grant
    Filed: October 19, 2016
    Date of Patent: December 8, 2020
    Assignees: The Brigham and Women's Hospital, Inc., Children's Medical Center Corporation
    Inventors: Martin Pollak, Elizabeth J. Brown, Johannes Schlondorff
  • METHODS FOR DIAGNOSING AND ASSESSING RISK OF DEVELOPING GLOMERULOSCLEROSIS
    Publication number: 20170096707
    Abstract: This document features method related to variants in the Inverted Formin 2 (INF2) gene that are associated with susceptibility to focal segmental glomerulosclerosis (FSGS). For example, methods of using such variants for risk assessment and for diagnosing and optimizing treatment of FSGS are provided.
    Type: Application
    Filed: October 19, 2016
    Publication date: April 6, 2017
    Inventors: Martin Pollak, Elizabeth J. Brown, Johannes Schlondorff
  • Methods for diagnosing and assessing risk of developing glomerulosclerosis
    Patent number: 9499867
    Abstract: This document features method related to variants in the Inverted Formin 2 (INF2) gene that are susceptibility to focal segmental glomerulosclerosis (FSGS). For example, methods of using such variants for risk assessment and for diagnosing and optimizing treatment of FSGS are provided.
    Type: Grant
    Filed: December 7, 2010
    Date of Patent: November 22, 2016
    Assignees: The Brigham and Women's Hospital, Inc., Children's Medical Center Corporation
    Inventors: Martin Pollak, Elizabeth J. Brown, Johannes Schlondorff
  • METHODS FOR DIAGNOSING AND ASSESSING RISK OF DEVELOPING GLOMERULOSCLEROSIS
    Publication number: 20130109630
    Abstract: This document features method related to variants in the Inverted Formin 2 (INF2) gene that are susceptibility to focal segmental glomerulosclerosis (FSGS). For example, methods of using such variants for risk assessment and for diagnosing and optimizing treatment of FSGS are provided.
    Type: Application
    Filed: December 7, 2010
    Publication date: May 2, 2013
    Applicant: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: Martin Pollak, Elizabeth J. Brown, Johannes Schlondorff